Discovery of pyrrolopyridazines as novel DGAT1 inhibitors

被引：27

作者：

Fox, Brian M. ^{[1
]}

Iio, Kiyosei ^{[2
]}

Li, Kexue ^{[1
]}

Choi, Rebeka ^{[1
]}

Inaba, Takashi ^{[2
]}

Jackson, Simon ^{[1
]}

Sagawa, Shoichi ^{[2
]}

Shan, Bei ^{[1
]}

Tanaka, Masahiro ^{[2
]}

Yoshida, Atsuhito ^{[2
]}

Kayser, Frank ^{[1
]}

机构：

[1] Amgen Inc, Amgen S San Francisco, San Francisco, CA 94080 USA

[2] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Osaka 5691125, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 20期

关键词：

DGAT1; inhibitors; Pyrrolopyridazines; Acyl CoA: diacylglycerol acyltransferase; COA-DIACYLGLYCEROL ACYLTRANSFERASE; TRIGLYCERIDE SYNTHESIS; OBESITY; CLONING; RESISTANCE; INSULIN; FAMILY; TARGET;

D O I：

10.1016/j.bmcl.2010.08.066

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

new structural class of DGAT1 inhibitors was discovered and the structure-activity relationship was explored. The pyrrolotriazine core of the original lead molecule was changed to a pyrrolopyridazine core providing an increase in potency. Further exploration resulted in optimization of the propyl group at C7 and the discovery that the ester at C6 could be replaced by five-membered heterocyclic rings. The analogs prepared have DGAT1 IC(50) values ranging from >10 mu M to 48 nM. (c) 2010 Elsevier Ltd. All rights reserved.

引用

页码：6030 / 6033

页数：4

共 50 条

[1] Discovery of pyrrolopyridazines as novel DGAT1 inhibitors
Fox, Brian M.
Iio, Kiyosei
Li, Kexue
Inaba, Takashi
Jackson, Simon
Choi, Rebekah
Sagawa, Shoichi
Shan, Bei
Tanaka, Masahiro
Yoshida, Atsuhito
Kayser, Frank
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
[2] Discovery of a novel class of diacylglycerol acyltransferase 1 (DGAT1) inhibitors
Shi, Qing
Schaus, John
Hammond, Craig
Lavallette, Lucille
O'Farrell, Libbey
Bauer, Steven
Lockwood, John
Yang, Nengyu
Lu, Yuefeng
Canada, Emily
He, Michelle M.
Brozinick, Joseph
Coskun, Tamer
Rubio, Almudena
Honigschmidt, Nicholas
Benesh, Dana
Arnold, Macklin Brian
Hembre, Erik
Galka, Chris
Bell, Mike
Hoogestraat, Paul
Pfeifer, Lance
Dao, Yen
Krushinski, Joseph
Ruley, Kevin
Beauchamp, Tom
Lu, Jianliang
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
[3] Discovery of novel, conformationally restricted, and orally efficacious DGAT1 inhibitors
Li, Kexue
Fox, Brian
Zhang, Jian
Iio, Kiyosei
Suzuki, Masahiro
Soichiro, Ito
Ozeki, Hidekazu
Kobayashi, Akio
Ma, Ji
Hao, Alan
Labelle, Marc
McMinn, Dustin
Smith, Marie
Sagawa, Shoichi
Furukawa, Noboru
Inaba, Takashi
Matsushita, Mutsuyoshi
Matsui, Takuya
Ogawa, Nobuya
Okuma, Chihiro
Sugimoto, Kazuyuki
Tanaka, Masahiro
Yoshida, Atsuhito
Ishii, Yukihito
Tomimoto, Daisuke
Jackson, Simon
Choi, Rebekah
Shan, Bei
Srivastava, Ajit
Kayser, Frank
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[4] Discovery of novel quinoline carboxylic acid series as DGAT1 inhibitors
Zhou, Gang
Ting, Pauline C.
Wishart, Grant
Zorn, Nicolas
Aslanian, Robert G.
Lin, Mingxiang
Smith, Michelle
Walker, Scott S.
Cook, John
Van Heek, Margaret
Lachowicz, Jean
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (07) : 1790 - 1794
[5] Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitors
Nakajima, Katsumasa
April, Myriam
Brewer, Jason T.
Daniels, Thomas
Forster, Cornelia J.
Gilmore, Thomas A.
Jain, Monish
Kanter, Aaron
Kwak, Youngshin
Li, Jingzhou
McQuire, Les
Serrano-Wu, Michael H.
Streeper, Ryan
Szklennik, Paul
Thompson, James
Wang, Bing
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (04) : 1245 - 1248
[6] Accelerating the discovery of DGAT1 inhibitors through the application of parallel medicinal chemistry (PMC)
Yu, Yang
Wu, Zhicai
Shi, Zhi-Cai
He, Shuwen
Lai, Zhong
Cernak, Timothy A.
Vachal, Petr
Liu, Min
Liu, Jian
Hong, Qingmei
Jian, Tianying
Guiadeen, Deodial
Krikorian, Arto
Sperbeck, Donald M.
Verras, Andreas
Sonatore, Lisa M.
Murphy, Beth A.
Wiltsie, Judyann
Chung, Christine C.
Gorski, Judith N.
Liu, Jinqi
Xiao, Jianying
Wolff, Michael
Tong, Sharon X.
Madeira, Maria
Karanam, Bindhu, V
Shen, Dong-Ming
Balkovec, James M.
De Vita, Robert J.
Pinto, Shirly
Nargund, Ravi P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (11) : 1380 - 1385
[7] Discovery of triazolopyridines as potent and selective acyl-CoA: Diacylglycerol acyltranferase 1 (DGAT1) inhibitors
Sun, Chongqing
Huang, Yanting
Tuerdi, Huji
Chao, Hannguang
Peterson, Tara
Dong, Jessica
Chu, Ching-Hsuen
Ma, Zhengping
Chen, Luping
Seethala, Ramakrishna
Harvey, Susan
Godonis, Helen
Rooney, Suzanne
Devenny, James
Pelleymounter, Maryann
Cai, Hong
Fura, Aberra
Ewing, William
Poss, Michael
Cheng, Dong
Lawrence, R. Michael
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
[8] Discovery of novel DGAT1 inhibitors by combination of machine learning methods, pharmacophore model and 3D-QSAR model
Hui Zhang
Chen Shen
Hong-Rui Zhang
Wen-Xuan Chen
Qing-Qing Luo
Lan Ding
Molecular Diversity, 2021, 25 : 1481 - 1495
[9] Discovery of novel DGAT1 inhibitors by combination of machine learning methods, pharmacophore model and 3D-QSAR model
Zhang, Hui
Shen, Chen
Zhang, Hong-Rui
Chen, Wen-Xuan
Luo, Qing-Qing
Ding, Lan
MOLECULAR DIVERSITY, 2021, 25 (03) : 1481 - 1495
[10] Synthesis and structure-activity relationship of novel biarylcinnamamide derivatives as potent DGAT1 inhibitors
Ohno, Hiroyuki
Tsutsumi, Takaharu
Takahashi, Katsushi
Ishii, Toshihiro
Minamizono, Kunio
Kurokawa, Masayuki
Katoh, Hirotsugu
Suga, Akiko
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247

← 1 2 3 4 5 →